- Alternative title
-
Identifizierung niedermolekularer Sonden für Kinasen durch chemische Proteomik
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
München, Technische Universität München, Dissertation, 2020
- Keyword
-
Proteomics
- Event
-
Veröffentlichung
- (where)
-
München
- (who)
-
Universitätsbibliothek der TU München
- (when)
-
2020
- Creator
-
Reinecke, Maria
- Contributor
- URN
-
urn:nbn:de:bvb:91-diss-20200911-1543206-1-3
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:42 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Reinecke, Maria
- Küster, Bernhard
- Jost, Philipp J.
- Knapp, Stefan
- Universitätsbibliothek der TU München
Time of origin
- 2020
Other Objects (12)
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
![Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Development and application of small molecule probes for kinase affinity purification and quantitative chemical proteomics
Computational Proteomics
Quantitative chemical proteomics for cancer characterization
Studying in vitro-differentiated hepatocytes by proteomics
Mass spectrometry based chemical proteomics for drug selectivity profiling
Design of cleavable linkers and applications in chemical proteomics
Profiling the phosphotyrosine interactome of receptor tyrosine kinases by affinity enrichment-mass spectrometry
Application of mass spectrometry-based proteomics to study cancer drug resistance mechanisms
Transcriptomics and Proteomics of Platelet Heterogeneity : From RNA-Sequencing to Mass Cytometry
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Development and application of small molecule probes for kinase affinity purification and quantitative chemical proteomics
Computational Proteomics
Quantitative chemical proteomics for cancer characterization
Studying in vitro-differentiated hepatocytes by proteomics
Mass spectrometry based chemical proteomics for drug selectivity profiling
Design of cleavable linkers and applications in chemical proteomics
Profiling the phosphotyrosine interactome of receptor tyrosine kinases by affinity enrichment-mass spectrometry
Application of mass spectrometry-based proteomics to study cancer drug resistance mechanisms
Transcriptomics and Proteomics of Platelet Heterogeneity : From RNA-Sequencing to Mass Cytometry
Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.
Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen
Untersuchungen über den photolytischen Abbau von aromatischen Polyamiden und Stabilisierung gegen UV-Licht mit substituierten Benztriazolen
Development and application of small molecule probes for kinase affinity purification and quantitative chemical proteomics
Computational Proteomics
Quantitative chemical proteomics for cancer characterization
Studying in vitro-differentiated hepatocytes by proteomics
Mass spectrometry based chemical proteomics for drug selectivity profiling
Design of cleavable linkers and applications in chemical proteomics
Profiling the phosphotyrosine interactome of receptor tyrosine kinases by affinity enrichment-mass spectrometry
Application of mass spectrometry-based proteomics to study cancer drug resistance mechanisms